Sanofi India Ltd share Price Today

Sanofi India Limited, founded in 1956 as Hoechst Fedco Pharma Private Limited, offers therapeutic pharmaceutical products for the treatment of diabetes, cardiac and neurological conditions, and various other ailments. The company is a subsidiary of Sanofi SA (a French company), one of the leading pharmaceutical companies in the world. It has its registered office in Mumbai, Maharashtra.

On 10 February 2023, the market capitalisation of the company was Rs 12,208.73 crore. It reported consolidated sales of Rs 2,956 crore at the end of October 2022. The company is listed on the Bombay Stock Exchange with the code 500674 and the National Stock Exchange with the code SANOFI.

On 31 December 2022, the company’s shareholding pattern indicated a promoter stake of 60.4% with a 6.99% stake of foreign institutional investors. Mutual funds and DIIs held a consolidated stake of 19.22%, and the public held a stake of 13.9% in the company. The company’s shareholding pattern has remained largely consistent over the past year. 

The company’s board of directors comprises Aditya Narayan, Rajaram Narayanan, Vaibhav Karandikar, Cherian Mathew, Charles Billard, Marc Antoine Lucchini, Rahul Bhatnagar, Usha Thorat, and others. The auditors are Price Waterhouse & Co Chartered Accountants LLP. On 30 September 2022, the company had a total of 2.3 crore shares outstanding.

On 10 February 2023, Sanofi India’s share price on BSE was Rs 5,331.60 and Rs 5,331.80 on NSE. The share price touched a 52-week high of Rs 9,265.00 and a 52-week low of Rs 5,258.00. Its three-month return to investors was -5.25%, while its one-year return was -27.96%.

On November 2022, Aditya Birla SL Frontline Equity Direct Fund-Growth invested Rs 188.97 crore in the company, while Nippon India Growth Direct-G and Nippon India Pharma Direct-G invested Rs 132.73 and Rs 130.26 crore, respectively.

 On November 2022, the company had a trailing twelve-month (TTM) revenue of Rs 2,956.60 crore. The company also had a net profit of Rs 944.40 during the same period.

The company’s peers include Sanofi India, Abbott India, GSK Pharma, and Pfizer.

Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code: 07730), BSE Ltd (Member Code: 103) and Member of Multi Commodity Exchange of India Ltd.(Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Ms. Mamta Shetty, Contact number: 022-40701022, E-mail address: complianceofficer@icicisecurities.com. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. Investors should consult their financial advisers if in doubt about whether the product is suitable for them. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

Sanofi India share price as on 11 Sep 2024 is Rs. 7219.25. Over the past 6 months, the Sanofi India share price has decreased by 14.76% and in the last one year, it has increased by 1.61%. The 52-week low for Sanofi India share price was Rs. 5892.8 and 52-week high was Rs. 10524.95.